METROPOLITAN LIFE INSURANCE CO/NY - KINNATE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 78 filers reported holding KINNATE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$11,156
-8.9%
1,785
-11.1%
0.00%0.0%
Q4 2022$12,249
-44.7%
2,008
+8.4%
0.00%0.0%
Q3 2022$22,131
-5.2%
1,8520.0%0.00%0.0%
Q2 2022$23,354
+12.0%
1,8520.0%0.00%0.0%
Q1 2022$20,854
-84.3%
1,852
-75.3%
0.00%
-50.0%
Q4 2021$133,077
-23.0%
7,5100.0%0.00%
-33.3%
Q3 2021$172,880
+18.2%
7,510
+60.0%
0.00%
+50.0%
Q1 2021$146,234–4,693–0.00%–
 Download
Other shareholders

There were no reported owners of KINNATE BIOPHARMA INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of KINNATE BIOPHARMA INC shareholders